Workers’ Compensation Medical Inflation Holds Steady in Q1 2026 as Broader Price Pressures Build

Why It Matters

The divergence signals that workers’ compensation insurers may face rising claim severity despite current low overall inflation, affecting reserve strategies and pricing for employers and self‑funded plans.

Key Takeaways

• WCWMI up 1.8% YoY in March, lagging consumer medical inflation
• Hospital outpatient costs grew 0.9%, far below September’s 2.9% rise
• Inpatient prices jumped 3.7% YoY, exceeding 2015‑2019 average
• Medical equipment prices surged 4.1% YoY, hinting at tariff effects
• Drug prices fell 0.2% YoY as federal price‑containment measures took hold

Pulse Analysis

The National Council on Compensation Insurance (NCCI) released its Q1 2026 Workers’ Compensation Weighted Medical Index, showing a modest 1.8% year‑over‑year rise in March. That pace sits well below the 4.0% increase in consumer‑paid medical costs and the 2.4% climb in the health‑care services producer price index. At the same time, headline CPI spiked to 3.3% in March, driven by energy price shocks, while core CPI held at 2.6%. NCCI warns that these broader price pressures could eventually filter into workers’ compensation costs, widening the gap between consumer and employer‑paid medical expenses. Analysts see the consumer‑workers’ compensation pricing gap as a leading cost‑pressure signal.

Outpatient hospital care, which carries a 28% weight in the index, slowed dramatically to 0.9% growth, far under its one‑year average of 2.8%. In contrast, inpatient hospital services—representing 12% of the index—rose 3.7% YoY, well above the 2015‑2019 average of 2.1%. Physician fees, the largest component at 39%, were steady at 1.4% growth. Notably, medical equipment and supplies surged 4.1% YoY, reflecting early tariff impacts, while drug prices slipped 0.2% as federal price‑containment policies took effect. Long‑term care, a 6% weight, rose 3.1% YoY, adding to high‑cost pressure.

For insurers and self‑funded employers, the modest overall index masks divergent trends that could reshape reserve calculations. Persistent inpatient inflation and rising equipment costs suggest upward pressure on claim severity, while declining drug prices provide a counterbalance. NCCI projects the WCWMI will gravitate toward its 2024‑2025 levels of roughly 2.5% later this year, implying that the current low‑inflation window may be temporary. Stakeholders should monitor tariff developments and federal drug‑pricing initiatives, as they will likely dictate the next phase of workers’ compensation medical cost dynamics. Employers might renegotiate fee schedules or use alternative networks to curb spikes.